Latest filing published 27 Jun 2022 for Aldeyra Therapeutics, Inc., €14k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +93.7%Entry US$3.99 · Close at T+365 US$7.73
- +20.7%Entry US$5.89 · Close at T+365 US$7.11
- +49.0%Entry US$5.00 · Close at T+365 US$7.45
- +88.0%Entry US$4.32 · Close at T+365 US$8.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Martin Joseph Joyce: trading record in brief
Filings by Martin Joseph Joyce span 2 companies, the busiest being Aldeyra Therapeutics, Inc. and Biosphere Medical Inc. Over a trading history stretching from 1 June 2006 to 23 June 2022, the count stands at 8 filings.
Purchases make up the whole of the open-market record (6 purchases, €118k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant. So far in 2022, the count stands at 1 purchase and no sales.
A typical purchase (the median) is worth €12k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. After 4 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at +12.7%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 27 June 2022, the filings show an open-market purchase worth €14k in Aldeyra Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Martin Joseph Joyce
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,323 shares@ US$3.4755100.0% of flowCommon StockSEC:0000899243-22-024133:0Canonical exit: 21 Sept 2022 (T+90)
- 1,700 shares@ US$5.8638.7% of flowCommon StockSEC:0000899243-19-023628:0Canonical exit: 11 Dec 2019 (T+90)
- 4,444 shares@ US$4.5044.6% of flowCommon StockSEC:0000899243-17-004752:0Canonical exit: 18 May 2017 (T+90)
- 1,000 shares@ US$3.95Common StockSEC:0001209191-14-051266:0Canonical exit: 5 Nov 2014 (T+90)
- 152,000 shares@ US$4.38Common StockSEC:0001179110-10-013652:0
- 47,000 shares@ US$0.01Common StockSEC:0001179110-10-003912:0
6 of 6 declarations
